Methods for monitoring and controlling foam in containers
By measuring the difference between the phase interface and the liquid level in the bioreactor, and using electromagnetic or radio wave signals to monitor the foam thickness and control the addition of defoamer, the problem of difficult monitoring and control of foam thickness in the bioreactor is solved, and precise foam management and effective use of defoamer are achieved.
Patent Information
- Application Number
- CN202580028844.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2024-04-19
- Filing Date
- 2025-04-17
- Publication Date
- 2026-11-17
AI Technical Summary
Existing technologies are insufficient to effectively monitor and control foam thickness within bioreactors, leading to adverse effects of foam formation on the manufacturing process. Furthermore, existing methods cannot provide accurate foam volume measurement and guidance for defoamer addition.
Foam thickness is monitored by measuring the difference between the phase interface and the liquid level using electromagnetic or radio wave signals, and the dosage of defoaming additives is controlled based on the measurement results. The signal emission and reflection times are used to determine the phase interface level.
It enables real-time monitoring and control of foam thickness, reduces the amount of defoamer used, ensures that the foam is within the allowable range, and avoids the negative impact of excessive or insufficient defoamer on production.
Smart Images

Figure CN123125316A_ABST
Abstract
Description
[0001] Cross-references to related applications
[0002] This application claims priority to U.S. Provisional Application No. 63 / 636,263, filed April 19, 2024, which is incorporated herein by reference in its entirety. Technical Field
[0003] This invention relates to a method for monitoring and controlling foam within a container containing liquid. Background Technology
[0004] Foam formation in bioreactors during manufacturing processes is a known problem. Foaming is undesirable because it adversely affects the manufacturing process. Examples of adverse effects include cell retention in the foam, pressure shocks due to clogging of aeration filters, spill risks, and contamination. Therefore, it is necessary to reduce foam formation within bioreactors.
[0005] However, this is constrained by the desire to increase production output, which may require conditions conducive to foam formation (e.g., blowing gas through liquid in a bioreactor vessel, stirring, or high-intensity incubation).
[0006] Therefore, for a given manufacturing process, completely eliminating foam formation in a bioreactor may be undesirable or impossible. One method to control foam formation is to add defoaming additives to the liquid in the bioreactor vessel. However, adding defoaming additives is not a complete solution, as excessive amounts can negatively impact production yield and quality. Therefore, attempts have been made to keep the foam formed within the bioreactor within an acceptable foam volume.
[0007] This has been achieved by periodically adding defoaming additives to the bioreactor during the manufacturing process. When excessive foam is detected, defoaming additives are introduced to restore the amount of foam to an acceptable level. To reduce this foam to an acceptable level, the amount of foam within the bioreactor must be monitored.
[0008] Monitoring the volume of foam within a bioreactor presents challenges for several reasons. Bioreactors can be constructed from opaque materials such as stainless steel, making direct observation of the foam within the container impossible. Foam may also accumulate around the container walls rather than away from them; therefore, even if the bioreactor is made of transparent material, any visual readings obtained could be inaccurate in representing the amount of foam in the container. Such methods further require personnel to take these readings and act accordingly.
[0009] Efforts have been made to automate the monitoring of foam thickness within bioreactors and to obtain indirect or non-visual readings, such as US2021 / 355427A1, which discloses the use of vision systems in biomanufacturing processes. Solutions include using cameras located within the container or positioned to view the contents through an observation window; however, cameras can be obstructed, and the output requires manual review. Another attempt, outlined by Endress+Hauser, utilizes the reduction in radar signal strength to detect foam presence; however, this does not provide the quantitative foam volume measurements needed to guide the precise addition of defoamers in bioreactors. Capacitive sensors are also deployed in the form of adhesive patches attached to the sidewalls of bioreactor containers (e.g., disposable bags). However, such patches only provide foam thickness in the immediate vicinity of the container wall. The information provided may not represent the entire liquid interface and can therefore lead to erroneous or unreliable readings. Furthermore, when bioreactor containers are formed from disposable bioreactors or bags, capacitive sensors typically need to be disposed of after the manufacturing process, increasing waste and cost.
[0010] Previous solutions also failed to address the issue that liquid levels within bioreactor vessels can vary due to normal manufacturing processes, such as changes in liquid volume caused by the introduction of reagents (e.g., fresh culture medium or supplements). This further complicates the determination of foam thickness within the bioreactor liquid.
[0011] The present invention aims to at least partially solve the problems pointed out above. Summary of the Invention
[0012] According to the present invention, a method for monitoring and controlling foam within a container containing liquid is provided, the method comprising:
[0013] a) Measure the thickness of foam within a container containing liquid; and
[0014] b) Control the dosage of the defoaming additive to be added to the liquid based on the measured thickness of the foam;
[0015] The thickness of the foam in step a is determined based on the difference between the level at the phase interface and the level of the liquid; and
[0016] The level of the phase interface is determined by a signal emitted toward and reflected from the phase interface.
[0017] A "phase interface" is the interface between two states of matter. For example, in the current case, this might be the interface between foam and gas in the top space of a container, or (if foam is absent) the interface between liquid and gas in the top space of a container. The level of a phase interface, or phase interface level, refers, for example, the height of the phase interface accumulated with the height of the liquid in the container. Phase interfaces can be distinct or continuous (e.g., in different cases, the transition between the foam state and the gas state is explicit, or the transition between the foam state and the gas state is not obvious, and there is a transition region between the two states). The determination of the liquid level is independent of the thickness of the foam. The level of a liquid, or liquid level, refers, for example, the height of the liquid in a container. The liquid level can be determined based on the amount of liquid present in the container when there is no foam (i.e., before foam formation), and / or the liquid level can be determined using methods that are largely independent of the presence or absence of foam. For example, the liquid level can be determined by measuring the mass of the contents of the container as a liquid (although mass includes the mass of the liquid and the mass of the foam, the mass of the foam is generally not important compared to the mass of the liquid, and therefore it can be assumed that mass is related to the liquid level). The term "quantity" in this document can be based on any suitable characteristic that can be used to determine the level of a liquid within a container, such as mass, volume, or depth, and the "level of the liquid" can be determined based on each of these characteristics. "Foam thickness" can be a relative measure, for example, compared to the level of the liquid, or an absolute measure, such as the distance between the phase interface and the receiver of the reflected signal. Foam thickness, or foam density, refers to, for example, the difference between the level at the phase interface and the level of the liquid.
[0018] The level at the phase interface can be determined based on the time elapsed between the transmission of the signal and the detection of the reflected signal. Therefore, the level at the phase interface can be determined based on the time of flight of the interrogation signal to be transmitted and reflected from the phase interface.
[0019] The signal may include electromagnetic radio waves or radio waves. The signal can be any signal suitable for providing the intended function, whereby the signal allows for the recording of time of flight to determine the phase interface level. It is evident that some types of signals are suitable for a given medium, while others are less suitable, for example, if the medium is transparent to that particular signal or is an absorber of that signal. The medium should be a reflector of the selected signal.
[0020] The signal may include radio waves in the range of 26 GHz to 170 GHz. Radio signals in the above range are resistant to attenuation / reduction from water droplets suspended in the overhead space (e.g., due to jetting).
[0021] Signals can be emitted toward and reflected from different locations on the phase interface. In this way, the level at the phase interface can be determined as an average value or a “high point” (i.e., a region of the phase interface positioned closer to the receiver or farther from the liquid level than other regions of the phase interface). This explains a variety of phenomena, such as inhomogeneous foam formation, foam polymerization, agglomeration, aggregation, and / or the presence of menisci. The acceptable thickness of the foam may vary across the phase interface, thus allowing for a greater amount of foam in regions of the phase interface farther from other components, such as filters or containers, where excessive foam can negatively impact performance.
[0022] The level of a liquid can be determined by volumetric and / or dimensional measurements associated with the liquid. This volume can be predetermined (i.e., adding a known volume of liquid to a container of a given geometry) or determined directly via, for example, a liquid level sensor, a capacitive sensor, guided wave radar, etc. Alternatively, the volume of the liquid can be determined indirectly, such as by measuring the mass of the fluid in the container and then converting it to liquid volume via density calculation and container geometry. The methods used to determine the liquid volume can vary during the use of the container, with some methods being more suitable at different stages; for example, predetermined at the start of container use, with direct and / or indirect measurements used at later points in time.
[0023] The level of a liquid can be determined by the volume associated with the liquid, and the volume determination is based on the mass of the liquid.
[0024] The levels at the phase interface and the liquid can be measured essentially simultaneously. In this way, the thickness of the foam can be monitored in real time.
[0025] The dosage of the defoaming additive can be controlled based on the measured thickness of the foam. In particular, it can be controlled by comparing the measured thickness of the foam with a threshold thickness of the foam. When the amount of foam exceeds the threshold thickness of the foam, the dosage of the defoaming additive can be changed to ensure that the amount of foam remains below the threshold. The term "dosage" in this application can refer to any suitable measure or method for applying a defoamer to a liquid to maintain the foam thickness within a desired limit. Therefore, the dosage can be changed by varying the time interval between constant additions, or by varying the amount and / or concentration of the defoaming additive in the addition and the time between fixed dosages, or a combination of the above methods. For example, when the measured thickness of the foam is below the threshold thickness of the foam, the dosage may include no defoaming additive added, and when the measured thickness of the foam is above the threshold thickness of the foam, an equal sample (e.g., a constant amount) of defoaming additive is added.
[0026] The dosage of defoaming additives can be determined, at least in part, by the deviation of the measured level from the threshold level. In this way, the dosage can be adjusted according to the amount of foam in the container, thereby minimizing unnecessary or excessive addition of defoaming agents.
[0027] Threshold levels can be determined at least in part based on the available headspace in a container. Containers containing liquids typically further include headspace located above the liquid level and generally occupied by gas. The headspace can vary depending on changes in the liquid level and the container's constant or maximum volume. Therefore, the acceptable thickness of the foam can vary depending on the available headspace within the container at any given time. A relatively high liquid level can result in less headspace, and consequently, a lower acceptable foam thickness. Conversely, a relatively low liquid level can result in a relatively large amount of headspace, thereby increasing the acceptable foam thickness within the container. Thus, the threshold can account for the headspace within the container and its variations. The threshold can vary depending on the acceptable foam thickness within the container at any given time.
[0028] The threshold level can be at least partially set as a specific level of foam in the container relative to the level of the liquid. The threshold level can also be at least partially set as the rate of change of foam thickness, when a rapid increase in foam thickness is detected in the container, an antifoaming agent is added.
[0029] The dosage of defoaming additives can be controlled by adjusting the intervals between additions and / or the amount added at one time. As described elsewhere, the dosage can be varied by changing the time interval between constant additions, or by varying the amount and / or concentration added and the time between fixed doses, or a combination of the above methods. "Example" in this document refers to a specific, individual dose applied to the container. Therefore, the immediate dose may be unique in the amount of defoamer provided relative to other real-time doses previously applied or subsequently applied to the container. The total dosage of defoamer should also take into account the effect of the defoaming additive on cell culture performance. The greater the negative impact of the defoaming additive on the cell line, the more cautious one should be with the permissible amount of defoamer.
[0030] The container can be a bioreactor. The container can be a bioreactor with a volume ranging from about 1 L to about 50,000 L; however, as those skilled in the art will recognize, this method is applicable to bioreactors of any given size, shape and dimensions.
[0031] The liquid can be a cell culture medium containing cell culture medium and cells. Advantageously, this method can be adapted (e.g., in flight) to accommodate changing liquid properties, such as mass, density, tendency to form foam, degree of foam formation, and foam stability, all of which may change during the typical time course of the cell culture process.
[0032] This method can be performed during the duration of batch culture, fed-batch culture, or perfusion culture processes.
[0033] This method can be repeated multiple times during the cultivation period. Advantageously, if needed, the method can be performed throughout the entire cultivation process, thereby ensuring that the foam thickness is automatically controlled within acceptable levels.
[0034] Repetition can be facilitated by adding or subtracting a certain amount of liquid from the container and / or over a period of time. Therefore, the method can be performed "on demand," whenever and wherever desired, or when a rapid change in foam thickness is anticipated (e.g., by adding a reagent with known foam-forming properties).
[0035] This method can be repeated substantially continuously over the duration of the cultivation. The cultivation can have any suitable duration for it to complete or reach the desired final state. This duration can be minutes, hours, days, weeks, or months. As an example, a signal with a refresh rate of approximately 5 Hz can be used to provide 5 readings per second. Such a rate is short enough to capture rapid changes in foam thickness. Therefore, in the context of this application, "continuous" means repeatedly querying the foam thickness, rather than intermittently querying the foam thickness a single time, which would provide an average foam thickness over a period of time and obscure the peaks in the foam thickness.
[0036] According to a further embodiment, a method for producing a biological agent from cells is provided, the method comprising:
[0037] a) The cells are cultured in a cell culture medium in a bioreactor;
[0038] b) Measure the thickness of the foam within the bioreactor containing the cell culture medium;
[0039] c) Controlling the dosage of the defoaming additive to be added to the cell culture medium based on the measured thickness of the foam; and
[0040] d) Obtain the biological agent produced by the cultured cells;
[0041] The thickness of the foam in step b is determined based on the difference between the level at the phase interface and the level in the cell culture medium; and
[0042] The phase interface is determined by a signal emitted toward and reflected from the phase interface.
[0043] The level at the phase interface can be determined based on the time elapsed between the emission of the signal and the detection of the reflected signal.
[0044] Signals may include electromagnetic radio waves.
[0045] The signal may include radio waves in the range of 26 GHz – 170 GHz. The signal may optionally include 80 GHz radio waves. Radio signals in the above range are considered as a trade-off between the need to resist attenuation / reduction from water droplets suspended in the overhead space (e.g., due to jetting) and the need to reduce penetration through the foam, the latter being inherent to higher frequency radar signals.
[0046] Signals can be emitted toward different positions of the phase interface and reflected from different positions of the phase interface.
[0047] The level of cell culture medium can be determined by volume and / or size measurements associated with the cell culture medium.
[0048] The level of the cell culture medium can be determined by a volume measurement associated with the cell culture medium, wherein the volume measurement is based on the mass of the cell culture medium.
[0049] The levels at the phase interface and the levels in the cell culture medium were measured almost simultaneously.
[0050] The dosage of defoaming additives can be controlled by comparing the measured thickness of the foam with the threshold thickness of the foam.
[0051] The dosage of defoaming additives can be determined at least in part by the deviation of the measured level from the threshold level.
[0052] Threshold levels can be determined at least in part based on the available headspace in the container.
[0053] The dosage of defoaming additives can be controlled by adjusting the interval between additions and / or the amount of defoaming additive added at one time.
[0054] Bioreactors can have any suitable volume. For example, a bioreactor can have a volume ranging from about 1 L to about 50,000 L.
[0055] Cell culture medium may contain cell culture medium and cells.
[0056] Steps b) and c) can be performed during the duration of batch culture, fed-batch culture, or pour-over culture.
[0057] Steps b) and c) can be repeated multiple times during the culture period.
[0058] Replication can be promoted by adding or removing a certain amount of cell culture medium from the container and / or over a period of time.
[0059] Steps b) and c) can be repeated substantially continuously over the duration of the culture.
[0060] Step d) can be performed only at approximately the end of the culture period.
[0061] Step d) may include isolating biological agents from cell culture medium.
[0062] The biological agent can be at least one recombinant polypeptide, and the cell can be or include a eukaryotic cell containing a polynucleotide encoding the recombinant polypeptide.
[0063] The at least one recombinant polypeptide may be selected from fusion proteins, antibodies, antigens, enzymes, or vaccines.
[0064] According to a further embodiment, an apparatus is provided for controlling the thickness of foam within a container containing liquid, the apparatus comprising:
[0065] A container configured to contain a liquid;
[0066] A phase interface level measuring device configured to measure the level at a phase interface, the phase interface level measuring device comprising:
[0067] A transmitter configured to transmit signals toward the phase interface;
[0068] A receiver configured to detect the reflected signal from the phase interface;
[0069] A liquid level measuring device configured to measure the level of the liquid in the container; and
[0070] The processor is configured to;
[0071] The thickness of the foam is determined based on the difference between the level at the phase interface and the level of the liquid; and
[0072] The measured thickness of the foam indicates the dosage of defoaming additive to be added to the liquid.
[0073] In this article, "a container configured to contain liquid" means a container capable of holding and storing a certain volume of liquid, such that the container can be used to perform related tasks, such as cell culture and / or biopharmaceutical production.
[0074] The processor is typically arranged to communicate with the transmitter, receiver, and liquid level measuring device, such that the output from each device can be received by the processor to determine the foam thickness based on the difference between the level at the phase interface and the liquid level. The processor may be further arranged to communicate with the output, enabling it to issue instructions regarding the dosage of the defoaming additive. The output can be any suitable one that affects variations in the defoaming agent dosage.
[0075] A phase interface level measuring device can determine the level of a phase interface based on the time elapsed between emitting a signal toward the phase interface and detecting the reflected signal. Therefore, the device can be able to record the time when the signal is emitted and then received at the transmitter and receiver, respectively, such as recording locally at the respective transmitter and receiver, and then transmitting such times to a processor, or having the processor instruct the emission and wait for detection via the transmitter and receiver.
[0076] The transmitter and / or receiver can be arranged substantially perpendicular to the phase interface of the liquid in the container. In this way, the reflected signal is maximized.
[0077] The transmitter and / or receiver may be positioned above the top of the container.
[0078] The transmitter and / or receiver can be positioned outside the container to transmit or detect signals into the container, respectively. In a further alternative, the transmitter and / or receiver may at least partially penetrate the container wall. Positioning the transmitter and / or receiver outside the container facilitates ease of inspection, testing, and maintenance of the receiver and / or transmitter. The most significant advantage of mounting the radar outside the bioreactor is that it is outside the sterile boundary of the bioreactor, thus eliminating the need for cleaning and sterilization before the next use.
[0079] The transmitter and / or receiver can be arranged inside the container to transmit or detect signals within the container, respectively. Positioning the transmitter and / or receiver inside the container is advantageous because the method can be used with containers formed of materials that are opaque to the transmitted signals, since the signals do not need to pass through the opaque container and can instead be detected by the internal receiver.
[0080] The transmitter can be configured to transmit either electromagnetic radio waves or radio waves.
[0081] The transmitter can be configured to transmit radio waves in the range of 26 GHz – 170 GHz.
[0082] Liquid level measuring devices can be selected from load cells, scales, rangefinders, and guided wave radars. As described above, liquid level measuring devices can directly measure the liquid level (in the case of a rangefinder or guided wave radar), or indirectly measure the liquid level via density and / or volume calculations in the case of a load cell or weighing scale. Liquid level measuring devices may include devices for measuring the mass of the liquid (such as, but not limited to, load cells or scales), thereby allowing the volume to be calculated using the density of the liquid and the geometry of the container.
[0083] The container can be a bioreactor. The bioreactor can have a volume ranging from about 1 L to about 50,000 L.
[0084] The container may be formed at least partially of a signal-permeable material, and a transmitter and / or receiver may be arranged to transmit or detect signals through the signal-permeable material, respectively. Using a signal-transparent material is advantageous because the transmitter and / or receiver can be arranged outside the container, thereby separating the transmitter and / or receiver from the contents of the container.
[0085] The top of the container can be formed of a material that is transparent or permeable to the signal. The container can advantageously be formed of a material that is semi-transparent or transparent to the signal, with the appropriate material chosen depending on whether the signal includes electromagnetic radio waves or radio waves, such that the material is semi-transparent / transparent to the signal. Semi-transparent / transparent in this context means that the signal attenuates and / or decreases little or no as it passes through the material.
[0086] The container may be formed at least partially of a radio-opaque material. The container may have windows formed of a signal-transparent or translucent material, while the remainder of the container is formed of a signal-opaque material. This may be for performance, economic, structural, or other reasons, where the benefits of using a signal-opaque material guarantee its use, rather than having the entire container formed of a signal-transparent or translucent material.
[0087] The container may be formed at least in part from: stainless steel; glass; ceramic; and / or plastic film.
[0088] The container may include at least: a partially stainless steel outer shell; and a plastic film liner.
[0089] The processor can control the dosage of defoaming additives by comparing the measured thickness of the foam with the threshold thickness of the foam.
[0090] The processor controls the dosage of defoaming additives by measuring the deviation between the measured level and the threshold level.
[0091] The processor can be configured to repeatedly and / or continuously measure the thickness of foam and indicate the dosage of defoaming additive during the duration of cell culture. For example, the processor can be configured to indicate the dosage of aliquots (e.g., a constant number) of defoaming additive when the measured thickness of the foam is above a threshold thickness of the foam.
[0092] The device may further include an antifoaming additive injector configured to automatically inject antifoaming additive into a container when instructed by the processor. The antifoaming additive injector is arranged to communicate with the processor, such that it operates according to instructions from the processor. Attached Figure Description
[0093] For example, embodiments of the invention are further described below with reference to the accompanying drawings, wherein:
[0094] Figure 1 shows a cross-section of the container according to the first embodiment;
[0095] Figure 2 shows a second cross-section of the container according to the first embodiment;
[0096] Figure 3 shows a third cross-section of the container according to the first embodiment;
[0097] Figure 4 shows a cross-section of the container according to the second embodiment;
[0098] Figure 5 is a graph showing the changes in phase interface level, liquid level, and load sensor output over time;
[0099] Figure 6 is a graph showing the measured foam thickness over time with batch feeding; and
[0100] Figure 7 shows the measured foam thickness, various thresholds, and defoamer addition time as a function of time.
[0101] Figure 8 is a diagram of an exemplary cell culture system including an automated defoamer monitoring and addition system.
[0102] Figure 9 is a graph of cell culture operation, depicting the foam thickness (black line) (left side of the Y-axis) in response to various threshold foam thickness settings (gray dashed line) during cell culture, and the foam thickness (black line) (left side of the Y-axis) in response to the addition of defoamer (vertical gray dashed line on the X-axis) when the defoamer addition pump is turned on at different time points (X-axis) as the cell culture progresses, as well as the weight of the contents of the cell culture container (black dashed line) (right side of the Y-axis, kilograms). Detailed Implementation
[0103] Throughout the description and claims of this specification, the words “comprising” and “including” and variations thereof mean “including, but not limited to”, and they are not intended to exclude (nor exclude) other parts, additives, components, integers, or steps. Throughout the description and claims of this specification, the singular includes the plural unless the context requires otherwise. In particular, where the indefinite article is used, the specification shall be understood to be in consideration of both the plural and the singular unless the context requires otherwise.
[0104] Features, integers, properties, compounds, chemical parts, or groups described in connection with specific aspects, embodiments, or examples of the invention should be understood to be applicable to any other aspect, embodiment, or example described herein, unless incompatible therewith. All features disclosed in this specification (including any appended claims, abstract, and drawings) and / or all steps of any method or process disclosed thereby may be combined in any combination, except for at least some mutually exclusive combinations of these features and / or steps. The invention is not limited to the details of any of the foregoing embodiments. The invention extends to any novel feature or any novel combination of features disclosed in this specification (including any appended claims, abstract, and drawings), or to any novel step or any novel combination of steps of any method or process disclosed thereby.
[0105] Readers should note that all documents and files submitted concurrently with or prior to this specification and made publicly available together with this specification are incorporated herein by reference.
[0106] To avoid any doubt, it is hereby declared that the information disclosed above under the heading "Background Art" is relevant to this invention and should be understood as part of the disclosure of this invention.
[0107] All publications, patent applications, patents and other references mentioned herein are incorporated herein by reference in their entirety. In case of any conflict, this specification (including definitions) shall prevail.
[0108] definition
[0109] The terms used in this specification generally have their common meaning in the art, both in the context of this disclosure and in the specific context in which each term is used. Some terms are discussed below or elsewhere in the specification to provide additional guidance to practitioners in describing the compositions and methods of this disclosure and how they are made and used.
[0110] As used herein, the use of the word "a" or "one" in conjunction with the term "comprising" in the claims and / or specification may mean "a" or "one," but is also consistent with the meaning of "a" or "one or more," "at least one" or "one" and "a" or "more than one."
[0111] The terms “comprising,” “including,” “having,” “possessing,” “may,” “containing,” and variations thereof, as used herein, are intended to be open-ended transitional phrases, terms, or words and do not exclude the possibility of additional actions or structures. This disclosure also contemplates other embodiments that “comprising,” “consisting of,” and “substantially constitute” the embodiments or elements presented herein, whether or not explicitly stated.
[0112] The term "about" or "approximately" refers to an acceptable range of error for a particular value, as determined by one of ordinary skill in the art, where the acceptable range of error will depend in part on how the value is measured or determined, i.e., the limitations of the measurement system. For example, according to practice in the art, "about" may mean 3 or more standard deviations. Alternatively, "about" may represent a range of up to 20%, preferably up to 10%, more preferably up to 5%, and even more preferably up to 1% of a given value. Alternatively, particularly with respect to biological systems or processes, the term may mean within a certain order of magnitude of a value, preferably within 5 times, more preferably within 2 times.
[0113] The term "cell culture medium" refers to a fluid that can be used to culture cells, such as a (aqueous) fluid containing "cell culture medium" or "culture medium". The terms "cell culture medium" and "culture medium" refer to nutrient solutions used to grow mammalian cells, which typically provide at least one component from one or more of the following categories:
[0114] 1) Energy source, generally existing in the form of carbohydrates (such as glucose);
[0115] 2) All essential amino acids, and generally a basic group consisting of twenty amino acids plus cysteine;
[0116] 3) The requirement is for low concentrations of vitamins and / or other organic compounds;
[0117] 4) Free fatty acids; and
[0118] 5) Trace elements, which are defined as inorganic compounds or naturally occurring elements, and the required amount is usually at a very low concentration, generally in the micromolar range.
[0119] The nutrient solution may optionally be supplemented with one or more ingredients from any of the following categories:
[0120] 1) Hormones and other growth factors, such as insulin, transferrin, and epidermal growth factor;
[0121] 2) Salts and buffers, such as calcium, magnesium, and phosphates;
[0122] 3) Nucleosides and bases, such as adenosine, thymidine, and hypoxanthine; and
[0123] 4) Proteins and tissue hydrolysates.
[0124] "Culturing" cells refers to bringing cells into contact with a cell culture medium under conditions suitable for cell survival and / or growth and / or proliferation.
[0125] "Batch culture" refers to a culture in which all components for cell culture (including cells and all culture nutrients) are supplied to the culture bioreactor at the beginning of the culture process.
[0126] As used herein, “feed-batch cell culture” refers to batch culture in which cells and culture medium are initially supplied to the culture bioreactor, and additional culture nutrients are continuously or discontinuously supplied to the culture during the culture process, with or without periodic cell and / or product harvesting before the culture is terminated.
[0127] "Perfusion culture," sometimes called continuous culture, is the culture in which cells are confined in a culture medium by means of, for example, filtration, encapsulation, anchoring to microcarriers, and the continuous, gradual or intermittent (or any combination thereof) introduction of the culture medium and its removal from the culture bioreactor.
[0128] As used herein, the term "cell" refers to animal cells (e.g., mammalian cells), bacterial cells (e.g., Escherichia coli cells), fungal cells (e.g., yeast cells), cultured cells, host cells, recombinant cells, and recombinant host cells. Such cells are generally cell lines obtained from or derived from mammalian tissues or fungi, which are capable of growing and surviving when placed in a culture medium containing appropriate nutrients and / or growth factors.
[0129] As used herein, the term "cell line" includes cultures of reproducible (e.g., eukaryotic cells) mentioned herein. The eukaryotic cells of this cell line may be selected from any cells as defined herein.
[0130] The terms “host cell,” “host cell line,” and “host cell culture” are used interchangeably and refer to cells and their progeny from which exogenous nucleic acids may be subsequently introduced to create recombinant cells. These host cells may also be modified (i.e., engineered) to alter or eliminate the expression of certain endogenous host cell products (e.g., endogenous viral particles or endogenous host cell proteins). Host cells include “transformers” and “transformed cells,” which include primary transformed cells and their progeny derived from those primary transformed cells, regardless of passage number. Progeny do not need to be identical to the nucleic acid contents of the parent cells but may contain mutations. This document includes mutant progeny with the same function or biological activity as screened or selected in the original transformed cells. Introducing exogenous nucleic acids (e.g., by transfection) into these host cells creates recombinant cells derived from the original “host cell,” “host cell line,” or “host cell line.” The terms “host cell,” “host cell line,” and “host cell culture” may also refer to such recombinant cells and their progeny. The terms “recombinant cell,” “recombinant cell line,” and “recombinant cell culture” are used interchangeably and refer to cells and their progeny in which exogenous nucleic acids have been introduced to enable the expression of a desired recombinant product. The recombinant product expressed by such cells can be a recombinant protein, recombinant viral particles, or a recombinant viral vector. The term “mammalian host cell” or “mammalian cell” refers to a cell line derived from mammals that can grow and survive when placed in a monolayer culture or a suspension culture in a medium containing appropriate nutrients and growth factors. The essential growth factors for a particular cell line can be readily determined empirically without excessive experimentation, as described in *Mammalian Cell Culture* (Mather, JP, ed., Plenum Press, NY 1984) and Barnes & Sato, (1980) *Cell*, 22:649. Typically, cells are capable of expressing and secreting large amounts of a specific target protein into the culture medium.Examples of suitable mammalian host cells in the context of this disclosure may include Chinese hamster ovary cells / -DHFR (CHO, Urlaub and Chasin, Proc. Natl. Acad. Sci. USA, 77:4216 1980); dp12.CHO cells (EP 307,247, disclosed March 15, 1989); CHO-K1 (ATCC, CCL-61); young hamster kidney cells (BHK, ATCC CCL 10); mouse testicular supporting cells (TM4, Mather, Biol. Reprod., 23:243-251 1980); canine kidney cells (MDCK, ATCC CCL 34); HEK 293 cells; buffalo rat hepatocytes (BRL 3A, ATCC CRL 1442); and mouse mammary tumors (MMT 060562, ATCC CCL51). Exemplary mammalian cells include Chinese hamster ovary cells (CHO). Cells may contain polynucleotides encoding polypeptides.
[0131] As used herein, the term "biologic" refers to molecules produced by cells, such as proteins, polysaccharides, or lipids. Biologics can be biologically active molecules. Biologics can be recombinant peptides, such as those selected from fusion proteins, antibodies, antigens, enzymes, and vaccines. Biologics can be excreted from cells into the cell culture medium, which may facilitate the isolation of the biologics.
[0132] The term “expression” as used in this article, whether in its noun or verb form, refers to transcription and translation occurring within a host cell. The expression level of a product gene in a host cell can be determined based on the amount of corresponding mRNA present in the cell or the amount of protein encoded by the product gene produced by the cell. For example, mRNA transcribed from a product gene is ideally quantified by northern hybridization. (Sambrook et al., Molecular Cloning: A Laboratory Manual, pp. 7.3–7.57 (Cold Spring Harbor Laboratory Press, 1989)). Proteins encoded by product genes can be quantified by various methods, such as by measuring the protein’s biological activity or by employing assays unrelated to that activity, such as Western blotting or radioimmunoassay using antibodies capable of reacting with the protein. (Sambrook et al., Molecular Cloning: A Laboratory Manual, pp. 18.1–18.88 (Cold Spring Harbor Laboratory Press, 1989)). When referring to a reduction and / or elimination of the expression of one or more endogenous products relative to the expression of endogenous products in unmodified cells, such reduction and / or elimination includes a reduction and / or elimination of the active endogenous product, even though there is an mRNA encoding all or part of the endogenous product or an endogenous product translated from such mRNA.
[0133] As used herein, "polypeptide" generally refers to peptides and proteins having more than about ten amino acids. Polypeptides may be homologous to host cells or preferably exogenous, meaning that these polypeptides are heterologous to the host cells utilized, i.e., foreign, such as human proteins produced by Chinese hamster ovary cells or yeast polypeptides produced by mammalian cells. In some embodiments, mammalian polypeptides (polypeptides originally derived from mammalian organisms) are used, more preferably those polypeptides that are secreted directly into the culture medium.
[0134] The term "protein" means an amino acid sequence with a chain length sufficient to produce higher levels of tertiary and / or quaternary structures. This is to distinguish it from "peptides" or other small molecular weight drugs that do not possess such structures. Typically, proteins as defined herein will have a molecular weight of at least about 15 to 20 kD, preferably at least about 20 kD. Examples of proteins covered in this definition include host cell proteins as well as all mammalian proteins, particularly therapeutic and diagnostic proteins, such as therapeutic and diagnostic antibodies, and are generally proteins containing one or more disulfide bonds, including multi-chain polypeptides containing one or more interchain and / or intrachain disulfide bonds.
[0135] The term "glycoprotein" refers to a protein containing oligosaccharide chains covalently attached to amino acid side chains. During a process called glycosylation, oligosaccharides can attach to proteins via co-translation or post-translational modification. Exemplary glycoproteins include antibodies, which typically have N-linked oligosaccharides on each heavy chain.
[0136] The term "antibody" is used in the broadest sense herein and encompasses a wide variety of antibody structures, including but not limited to monoclonal antibodies, polyclonal antibodies, monospecific antibodies (e.g., antibodies consisting of a single heavy chain sequence and a single light chain sequence, including such paired multimers), multispecific antibodies (e.g., bispecific antibodies), and antibody fragments, provided they exhibit the desired antigen-binding activity. Therapeutic antibodies are antibodies that can be used to treat diseases.
[0137] As used herein, “antibody fragment,” “antigen-binding portion” of an antibody (or simply “antibody portion”), or “antigen-binding fragment” of an antibody refers to a molecule other than the intact antibody that contains the antigen-binding portion of the intact antibody. Examples of antibody fragments include, but are not limited to, Fv, Fab, Fab', Fab'-SH, F(ab')2; bisomatic antibodies; linear antibodies; single-chain antibody molecules (e.g., scFv and scFab); single-domain antibodies (dAb); and multispecific antibodies formed from antibody fragments. For a review of certain antibody fragments, see Holliger and Hudson, Nature Biotechnology 23:1126-1136 (2005).
[0138] The term "chimeric" antibody refers to an antibody in which a portion of the heavy chain and / or light chain originates from a specific source or species, while the remainder of the heavy chain and / or light chain originates from a different source or species.
[0139] As used herein, the term "titer" refers to the total amount of recombinant expressed antibody produced from a cell culture divided by a given volume of culture medium. Titers are typically expressed in milligrams of antibody per milliliter or liter of culture medium (mg / ml or mg / L). In some embodiments, titers are expressed in grams of antibody per liter of culture medium (g / L). Titers can be expressed or assessed based on relative measurements, such as the percentage increase in titer compared to protein products obtained under different culture conditions.
[0140] As used herein, the term "monoclonal antibody" refers to an antibody obtained from a substantially homogeneous group of antibodies, meaning that, apart from possible variant antibodies (e.g., those containing naturally occurring mutations or produced during the production of a monoclonal antibody formulation, such variants are typically present in small quantities), the individual antibodies constituting this group are identical and / or bind to the same epitopes. In contrast to polyclonal antibody formulations, which typically comprise different antibodies targeting different determinants (epitaxes), each monoclonal antibody in a monoclonal antibody formulation targets a single determinant on the antigen. Therefore, the modifier "monoclonal" indicates that the antibody is characterized by being obtained from a substantially homogeneous group of antibodies and should not be construed as requiring the antibody to be produced by any particular method. For example, monoclonal antibodies used in the currently disclosed subject matter can be prepared using a variety of techniques, including but not limited to hybridoma methods, recombinant DNA methods, phage display methods, and methods utilizing transgenic animals containing all or part of the human immunoglobulin loci, such methods and other exemplary methods for preparing monoclonal antibodies are described herein.
[0141] A "human antibody" is an antibody whose amino acid sequence corresponds to that of an antibody produced by a human or human cell, or to a non-human antibody derived from a complete library of human antibodies or other antibody-encoding sequences. This definition of a human antibody specifically excludes humanized antibodies containing non-human antigen-binding residues.
[0142] "Humanized" antibodies are chimeric antibodies comprising amino acid residues from a nonhuman complementarity-determining region (CDR) and amino acid residues from a human framework region (FR). In some respects, humanized antibodies will substantially comprise at least one, typically two, variable domains, wherein all or substantially all CDRs correspond to the CDRs of a nonhuman antibody, and all or substantially all FRs correspond to the FRs of a human antibody. Humanized antibodies may optionally comprise at least a portion of the antibody constant region derived from a human antibody. Antibodies in a "humanized form," such as nonhuman antibodies, refer to antibodies that have undergone humanization.
[0143] As used in this article, the term “enzyme” refers to a protein or polypeptide (such as a recombinant polypeptide) that acts as a biological catalyst.
[0144] As used herein, the terms “recombinant protein” and “recombinant polypeptide” generally refer to peptides and proteins (including antibodies) encoded by “heterologous” nucleic acids (i.e., nucleic acids that are foreign to the host cell used, such as those encoding human antibodies introduced into non-human host cells). Specific Implementation
[0145] Figure 1 shows an apparatus 100. The apparatus 100 has a container 101. This container is capable of containing a liquid 102 within its interior. The container 101 is at least partially made of: stainless steel; glass; ceramic; and / or plastic film or any other suitable material required by the manufacturing process. Liquid 102 can be added to or removed from the container 101 at will (e.g., from one or more inlets or outlets (not shown)), and the quantity of liquid 102 can be controlled or predetermined. Quantities as used herein can be specified in any suitable unit (such as, but not limited to, mass or volume). The container can be sealed or closed from the external environment (via a valve) (i.e., the container 101 includes a cavity), or the container can be open to the environment, provided that the container is still configured to contain liquid. The container can also be configured to provide a jet (not shown) of air, oxygen, or any other suitable gas to the contained liquid 102, and / or the container may include a stirrer (not shown) for mixing any contained liquid 102.
[0146] The apparatus 100 is further equipped with a phase interface level measuring device. The phase interface level measuring device, including a transmitter 103 and a receiver 104, can be attached to or detached from the container 101. Even when detached from the container 101, the phase interface level measuring device can still be arranged in contact with the container (if not attached), or spaced apart from the container, provided that the space does not impede the phase interface level measuring device from performing its intended function. The phase interface level measuring device provides the function of detecting the presence and location of a transition between two phases of matter (such as liquid-gas or foam-gas in this application). In this application, the phase interface level measuring device includes a transmitter 103 and a receiver 104.
[0147] Transmitter 103 is configured to transmit a signal toward the interior of container 101 such that the phase interface 105 is positioned along the path of signal propagation. The transmitted signal can be any signal discussed in this application, such as radio waves in the 26 GHz–170 GHz range. Because the phase interface 105 is positioned along the path of signal propagation, the phase interface acts as a reflector of the signal. The signal is reflected when it encounters the phase interface. The transmitted signal may not be entirely reflected. Part of the signal may be reflected by the phase interface. The amount of signal reflected can vary depending on the angle of incidence between the signal and the phase interface or the properties of the phase interface (i.e., the specific phase of the substance and the physical / chemical properties of the material forming the phase interface at any given time).
[0148] Receiver 104 is configured to detect a portion of the signal or a portion of the signal reflected back toward receiver 104. It is worth noting that the portion of the signal reflected back toward receiver may not be the entirety of the reflected signal. Phase interface 105 may scatter a portion of the reflected signal such that the path of that portion of the reflected signal does not coincide with receiver 104. Receiver may be arranged adjacent to transmitter, and receiver and transmitter may form part of a single unit. Alternatively, transmitter and receiver may be independent units arranged adjacent to each other. Further alternatively, transmitter and receiver may be arranged at separate locations spaced apart from each other, provided that receiver is arranged such that receiver is able to receive the signal transmitted from transmitter after reflection from phase interface.
[0149] Container 101 includes a wall configured to contain liquid 102. Since transmitter 103 and receiver 104 are arranged outside the container, the container wall should be formed of a signal-permeable material, at least in the vicinity of the locations of transmitter 103 and receiver 104, to allow signals to pass through.
[0150] A liquid level measuring device 106 is also provided. The liquid level measuring device can be any device as described in this application. As previously stated, the liquid level can be measured directly or indirectly. Direct methods include ranging devices and / or guided wave radar. Indirect methods include load sensors or scales. The container 101 shown in the figure is arranged on a scale as the liquid level measuring device 106.
[0151] A processor (not shown) is provided to communicate with the liquid level measuring device 106, the transmitter 103, and the receiver 104, and is arranged to receive signals from those elements.
[0152] The device 100 is further provided with an injector 107, which is arranged to release a pre-measured dose of defoamer into the container.
[0153] Referring to Figure 2, the apparatus 100 of Figure 1 is shown, and it has the same features and characteristics as previously described. Container 101 contains liquid 102, and a process is taking place within the container. Therefore, foam 200 is formed on top of liquid 102, typically between the top of the liquid and the top space 201 of container 101.
[0154] The headspace 201 is the working area of container 101, which is not currently occupied by liquid and / or foam. In other words, the headspace 201 is the space within the container that is not occupied by liquid or foam. The dimensions of the headspace 201 will change according to changes in the volume of liquid and / or foam (e.g., by adding or expanding the liquid volume). The headspace 201 is typically occupied by gas.
[0155] Foam 200 includes a liquid contact interface 205 between liquid 102 and foam 200, and a phase interface 202 between foam 200 and top space 201.
[0156] The figure shows transmitter 103 transmitting a signal 203 toward the foam top space interface 202. The transmitted signal 203 is reflected at the interface, and at least a portion of the reflected signal 204 is detected by receiver 104. The time of flight of the signal is calculated by the time taken from the transmission of the transmitted signal 203 to its detection at receiver 104 as the reflected signal 204. Therefore, the distance of the foam top space interface relative to receiver 104 can be determined, with a shorter duration indicating that the foam top space interface 202 is relatively closer to receiver 204 compared to a detection with a longer duration.
[0157] The liquid level measuring device 106 can provide the liquid level value in the container when there is no foam while detecting the signal. This liquid level value can be used to determine the volume of the container occupied by the liquid when there is no foam, and the rest of the container is the available top space 201.
[0158] The available top space 201 can then be compared with the distance between the foam top space interface and the receiver 104, thereby determining the foam thickness. If the detected foam thickness exceeds an acceptable value, the processor can instruct a change in the dosage of the defoaming additive. The dosage can be determined as previously described.
[0159] The defoaming additive can be supplied to the container 101 via injector 107 in a calculated dose to suppress foam.
[0160] The foam thickness can then be monitored continuously by detecting the phase interface at the top of the foam and by using a liquid level measuring device, repeating this process until the foam formation process within the container is complete. In this way, the foam thickness within the container can be automatically controlled without external input. This method does not rely on observing the contents of the container and can operate based on changes in the liquid volume.
[0161] The acceptable thickness of the foam can be defined as a threshold, which triggers a change in the dosage of the defoamer once the thickness is exceeded. In one instance, the dosage change includes not adding defoamer when the measured thickness of the foam is below the threshold, and adding an equal sample (e.g., a constant amount) of defoamer when the measured thickness of the foam is above the threshold.
[0162] Referring to Figure 3, the apparatus 100 of Figures 1 and 2 is shown, and it has the same features and characteristics as previously described. Similar reference numerals have been omitted to avoid unnecessarily obscuring the figure. The transmitter and receiver can be arranged to scan or otherwise read across the interface of the foam top space phase interface. This can span the entire area of the foam top space phase interface or another predetermined area.
[0163] Transmit signal 303 and detection signal 304 indicate an inquiry into the foam top space phase interface at a location remote from transmitter 103 and receiver 104. It is possible that the acceptable thickness of the foam within the container may be uneven, with the top space region within the container accommodating a larger amount of foam compared to other regions (e.g., those near, for example, filters).
[0164] By querying multiple locations across the phase interface of the top space of the foam, it is also possible to identify areas where the foam thickness increases relative to other areas, since foam formation within the container may be uneven.
[0165] Figure 4 depicts a device 400 similar to those in Figures 1 and 2, having the same features and characteristics as previously described. Similar reference numerals have been omitted to avoid unnecessarily obscuring the figure. Device 400 differs from the devices in the previous figures because the transmitter 403 and receiver 404 are arranged within the top space of the container, rather than outside the container as shown in Figures 1, 2, and 3. Other arrangements are also possible, as described elsewhere. Because the transmitter 403 and receiver 404 are arranged within the top space, the container need not be formed of a signal-permeable material and can instead be formed of a signal-opaque material.
[0166] Additional Examples
[0167] Further embodiments of the invention are described in the following numbered clauses:
[0168] Clause 1. A method for monitoring and controlling foam within a container containing liquid, the method comprising:
[0169] a) Measure the thickness of foam within a container containing liquid; and
[0170] b) Control the dosage of the defoaming additive to be added to the liquid based on the measured thickness of the foam;
[0171] The thickness of the foam in step a is determined based on the difference between the level at the phase interface and the level of the liquid; and
[0172] The level of the phase interface is determined by a signal emitted toward and reflected from the phase interface.
[0173] Clause 2. The method according to Clause 1, wherein the phase interface is the interface between the foam in the container and the headspace gas.
[0174] Clause 3. The method according to Clause 1, wherein the level of the phase interface is determined based on the time elapsed between the emission of the signal and the detection of the reflected signal.
[0175] Clause 4. The method according to any one of Clauses 1 to 3, wherein the signal includes any one of: electromagnetic radio waves; or radio waves.
[0176] Clause 5. The method described in any of the preceding clauses, wherein the signal comprises radio waves in the range of 26 GHz to 170 GHz.
[0177] Clause 6. The method according to any of the preceding clauses, wherein the signal is emitted toward and reflected from different locations of the phase interface.
[0178] Clause 7. The method according to any of the preceding clauses, wherein the level of the liquid is determined by volume measurement and / or size measurement associated with the liquid.
[0179] Clause 8. The method described in Clause 7, wherein the level of the liquid is determined by measuring the volume of the liquid.
[0180] Clause 9. The method described in Clause 8, wherein the volume determination is based on the mass of the liquid.
[0181] Clause 10. The method according to any of the preceding clauses, wherein the level at the phase interface and the level of the liquid are each measured substantially simultaneously.
[0182] Clause 11. The method according to any of the preceding clauses, wherein the dosage of the defoaming additive is controlled by comparing the measured thickness of the foam with a threshold thickness of the foam.
[0183] Clause 12. The method according to any of the preceding clauses, wherein the dosage of the defoaming additive is determined at least in part by the deviation of the measured level from the threshold level of Clause 11.
[0184] Clause 13. The method according to any of the preceding clauses, wherein the threshold level of Clause 9 is determined at least in part based on the available headspace in the container.
[0185] Clause 14. The method according to any of the preceding clauses, wherein the dosage of the defoaming additive is controlled by adjusting the interval of adding the defoaming additive and / or the amount of the defoaming additive added at one time.
[0186] Clause 15. The method according to any of the preceding clauses, wherein the container is a bioreactor with a volume ranging from about 1 L to about 50,000 L.
[0187] Clause 16. The method according to any of the preceding clauses, wherein the liquid is a cell culture medium containing cell culture medium and cells.
[0188] Clause 17. The method according to any of the preceding clauses, wherein the method is performed during the duration of batch culture, fed-batch culture, or perfusion culture.
[0189] Clause 18. The method described in any of the preceding clauses, wherein the method is repeated multiple times during the duration of the culture.
[0190] Clause 19. The method according to Clause 18, wherein the repetition is facilitated by adding or subtracting a certain amount of liquid from the container and / or over a period of time.
[0191] Clause 20. The method pursuant to Clause 16, wherein the method is substantially continuously repeated over the duration of the culture.
[0192] Clause 21. A method for producing a biological agent from cells, the method comprising:
[0193] a) Culture cells in cell culture medium in a bioreactor;
[0194] b) Measure the thickness of the foam within the bioreactor containing the cell culture medium;
[0195] c) Controlling the dosage of the defoaming additive to be added to the cell culture medium based on the measured thickness of the foam; and
[0196] d) Obtain the biological agent produced by the cultured cells;
[0197] The thickness of the foam in step b is determined based on the difference between the level at the phase interface and the level in the cell culture medium; and
[0198] The phase interface is determined by a signal emitted toward and reflected from the phase interface.
[0199] Claim 22. The method according to Clause 21, wherein the phase interface is the interface between the foam in the container and the headspace gas.
[0200] Clause 23. The method according to Clause 21, wherein the level of the phase interface is determined based on the time elapsed between the emission of the signal and the detection of the reflected signal.
[0201] Clause 24. The method according to any one of Clauses 21 to 23, wherein the signal includes any one of: electromagnetic radio waves; or radio waves.
[0202] Clause 25. The method according to any one of Clauses 21 to 24, wherein the signal comprises radio waves in the range of 26 GHz to 170 GHz, and optionally wherein the signal comprises 80 GHz radio waves.
[0203] Clause 26. The method according to any one of Clauses 21 to 25, wherein the signal is emitted toward and reflected from different locations of the phase interface.
[0204] Clause 27. The method according to any one of Clauses 21 to 26, wherein the level of the cell culture medium is determined by volume measurement and / or size measurement associated with the cell culture medium.
[0205] Clause 28. The method according to Clause 27, wherein the level of the cell culture medium is determined by a volume measurement associated with the cell culture medium, and wherein the volume measurement is based on the mass of the cell culture medium.
[0206] Clause 29. The method according to any one of Clauses 21 to 28, wherein the level at the phase interface and the level in the cell culture medium are each determined substantially simultaneously.
[0207] Clause 30. The method according to any one of Clauses 21 to 29, wherein the dosage of the defoaming additive is controlled by comparing the measured thickness of the foam with a threshold thickness of the foam.
[0208] Clause 31. The method according to any one of Clauses 21 to 30, wherein the dosage of the defoaming additive is determined at least in part by the deviation of the measured level from the threshold level of Clause 27.
[0209] Clause 32. The method according to any one of Clauses 21 to 31, wherein the threshold level of Clause 27 is determined at least in part based on the available headspace in the container.
[0210] Clause 33. The method according to any one of Clauses 21 to 32, wherein the dosage of the defoaming additive is controlled by adjusting the interval of adding the defoaming additive and / or the amount of the defoaming additive added at one time.
[0211] Clause 34. The method according to any one of Clauses 21 to 33, wherein the bioreactor has a volume in the range of about 1 L to about 50,000 L.
[0212] Clause 35. The method according to any one of Clauses 21 to 34, wherein the cell culture medium comprises cell culture medium and cells.
[0213] Clause 36. The method according to any one of Clauses 21 to 35, wherein steps b) and c) are performed during the duration of batch culture, fed-batch culture, or perfusion culture.
[0214] Clause 37. The method according to any one of Clauses 21 to 36, wherein steps b) and c) are repeated multiple times during the duration of the culture.
[0215] Clause 38. The method of claim 37, wherein the repetition is promoted by adding or subtracting a certain amount of cell culture medium from the container and / or over a period of time.
[0216] Clause 39. The method according to any one of Clauses 36 to 38, wherein steps b) and c) are substantially repeated continuously over the duration of the culture.
[0217] Clause 40. The method according to any one of Clauses 36 to 39, wherein step d) is performed only at approximately the end of the duration of the culture.
[0218] Clause 41 The method according to any one of Clauses 36 to 39, wherein step d) includes isolating the biological agent from the cell culture medium.
[0219] Clause 42. The method according to any one of Clauses 21 to 41, wherein the biological agent is at least one recombinant polypeptide and the cell is a eukaryotic cell containing a polynucleotide encoding the recombinant polypeptide.
[0220] Clause 43. The method according to Clause 42, wherein the at least one recombinant polypeptide is selected from fusion proteins, antibodies, antigens, enzymes or vaccines.
[0221] Clause 44. An apparatus for controlling the thickness of foam within a container containing liquid, the apparatus comprising:
[0222] A container configured to contain a liquid;
[0223] A phase interface level measuring device configured to measure the level at a phase interface, the phase interface level measuring device comprising:
[0224] A transmitter configured to transmit signals toward the phase interface;
[0225] A receiver configured to detect the reflected signal from the phase interface;
[0226] A liquid level measuring device configured to measure the level of the liquid in the container; and
[0227] The processor is configured to;
[0228] The thickness of the foam is determined based on the difference between the level at the phase interface and the level of the liquid; and
[0229] The measured thickness of the foam indicates the dosage of defoaming additive to be added to the liquid.
[0230] Clause 45. The apparatus of Clause 44, wherein the interface level measuring device measures the level of the interface based on the time elapsed between emitting the signal toward the interface and detecting the reflected signal.
[0231] Clause 46. The apparatus according to Clause 44 or 45, wherein the transmitter and / or receiver is arranged substantially perpendicular to the phase interface of the liquid in the container.
[0232] Clause 47. The apparatus according to any one of Clauses 44 to 46, wherein the transmitter and / or receiver is arranged above the top of the container.
[0233] Clause 48. The apparatus according to any one of Clauses 44 to 47, wherein the transmitter and / or receiver is arranged outside the container to transmit or detect signals into the interior of the container, respectively.
[0234] Clause 49. The apparatus according to any one of Clauses 44 to 48, wherein the transmitter and / or receiver are arranged inside the container to transmit a signal or detect a signal, respectively, within the container.
[0235] Clause 50. The apparatus according to any one of Clauses 44 to 49, wherein the transmitter is configured to emit any one of: electromagnetic radio waves; or radio waves.
[0236] Clause 51. The apparatus of Clause 50, wherein the transmitter is configured to transmit radio waves in the range of 26 GHz to 170 GHz.
[0237] Clause 52. The apparatus according to any one of Clauses 44 to 51, wherein the liquid level measuring device is selected from load sensors, scales, ranging devices, and guided wave radar.
[0238] Clause 53. The apparatus according to any one of Clauses 44 to 52, wherein the container is a bioreactor with a volume ranging from about 1 L to about 50,000 L.
[0239] Clause 54. The apparatus according to any one of Clauses 44 to 53, wherein the container is formed at least partially of a signal-permeable material, and wherein the transmitter and / or receiver are arranged to transmit or detect signals through the signal-permeable material, respectively.
[0240] Clause 55. The device according to any one of Clauses 44 to 54, wherein the top of the container is formed of a signal-permeable material.
[0241] Clause 56. The apparatus according to any one of Clauses 54 to 55, wherein the container is at least partially formed of a radio-impermeable material.
[0242] Clause 57. The apparatus according to any one of Clauses 54 to 56, wherein the container is formed at least in part from: stainless steel; glass; ceramic; and / or plastic film.
[0243] Clause 58. The apparatus according to any one of Clauses 54 to 57, wherein the container comprises at least: a partially stainless steel outer shell; and a plastic film liner.
[0244] Clause 59. The apparatus according to any one of Clauses 54 to 58, wherein the processor controls the dosage of the defoaming additive by comparing a measured thickness of the foam with a threshold thickness of the foam.
[0245] Clause 60. The apparatus of Clause 59, wherein the processor controls the dosage of the defoaming additive by measuring the deviation of the measured level from the threshold level.
[0246] Clause 61. The apparatus according to any one of Clauses 44 to 60, wherein the processor is configured to repeatedly and / or continuously measure the thickness of the foam and indicate the dosage of the defoaming additive during the duration of cell culture.
[0247] Clause 62. The apparatus according to any one of Clauses 44 to 61, wherein the apparatus further comprises an antifoaming additive injector configured to automatically inject the antifoaming additive into the container when the processor instructs the addition of the antifoaming additive.
[0248] Clause 63. Use of an apparatus according to any one of Clauses 44 to 62 for controlling the thickness of foam in a container, optionally said container being a bioreactor.
[0249] Clause 64. Use of an apparatus according to any one of Clauses 44 to 62 for culturing cell lines.
[0250] Clause 65. Use of the device according to Clause 64, wherein the cells are engineered to produce recombinant peptides;
[0251] Optionally, the recombinant polypeptide is a fusion protein, antibody, antigen, enzyme, or vaccine.
[0252] Clause 66. Use of an apparatus according to any one of Clauses 44 to 62 for producing a biological agent, wherein the container contains a cell culture medium containing a cell line engineered to produce the biological agent.
[0253] Clause 67. Use of the apparatus disclosed in Clause 66, wherein the biological agent is at least one recombinant polypeptide, and the cell line is a eukaryotic cell line containing a polynucleotide encoding the recombinant polypeptide;
[0254] Optionally, the recombinant polypeptide is a fusion protein, antibody, antigen, enzyme, or vaccine.
[0255] Clause 68. The use described in Clause 66 or Clause 67 further includes the isolation of biological agents.
[0256] Any defoaming additive or defoamer suitable for mammalian or prokaryotic cell culture may be used in the methods disclosed herein and other embodiments. In any embodiment herein, the defoaming additive or defoamer is a silicone-based defoamer comprising, for example, one or more of the following: simethicone; polydimethylsiloxane; and / or silica. In some embodiments, the defoaming additive or defoamer is LIVEO™ (DuPont™).
[0257] Example
[0258] Example 1: Continuous monitoring of foam inside a container
[0259] The apparatus, including a bioreactor, is equipped with a radar (80 GHz) and a load sensor positioned near the top of the bioreactor. The radar, including a transmitter and receiver, is positioned near the top of the bioreactor and configured to transmit and receive signals to enable the determination of the level at the phase interface within the bioreactor. The load sensor measures the mass of the cell culture in the bioreactor, which, based on the bioreactor's capacity and geometry, is converted to the liquid level using a previously determined calibration. The bioreactor further includes inlets for the separate addition of cell culture feed and defoaming additive. The bioreactor also includes devices for gas injection. The bioreactor communicates with a processor. The processor is configured to determine the liquid level based on the output of the load sensor, determine the foam thickness based on the difference between the phase interface level and the liquid level, and automatically add defoaming additive based on a pre-planned schedule.
[0260] Experiments were conducted to confirm the device's ability to continuously measure foam thickness in the bioreactor over extended periods. The results are presented in Figures 5 and 6.
[0261] Figure 5 is a graph showing the phase interface level, load sensor output, and the liquid level converted from the load sensor output over time in embodiments of this disclosure. The X-axis shows the passage of time over a 10-day process. The load sensor output is shown to change as the manufacturing process progresses. The unit of the load sensor output can be any suitable unit as described herein, provided that the load sensor output is usable for determining the liquid level in the absence of foam. As a non-limiting example, the change in the load sensor output can be a change in the liquid volume by adding / subtracting the growth of the liquid and / or the product in the container during a biological process.
[0262] The liquid level is expressed as a percentage of the container height, calculated based on the load sensor output shown in Figure 5. As can be seen from the figure (and as expected), the liquid level closely follows the load sensor output because the container is cylindrical in this example. Using percentages as the unit for liquid level and phase interface in the container offers the advantage of making it easier to transfer calculations for foam thickness from the processor to other containers.
[0263] In Figure 5, the phase interface level measured by radar is expressed as a percentage of the container height. The liquid level converted by the load sensor is also expressed as a percentage of the container height. Subtracting the percentage of liquid level in the container from the phase interface level percentage yields the percentage of foam thickness relative to the container height, which is then converted to the actual foam thickness (in inches) at any given moment in this case, as shown in Figure 6. As can be seen from the figure, the foam thickness is determined using the techniques described and plotted above. When foam is generated in the bioreactor container, the phase interface level is higher than the liquid level, and the foam thickness (in inches) is greater than 0. When there is no foam in the bioreactor, the foam thickness is zero.
[0264] Figure 6 shows the foam thickness (indicated by dots), which was determined by measuring the phase interface level and liquid level shown in Figure 5. The X-axis shows the passage of time over a 10-day process. During this process, periodic batch feeding (dashed lines) was performed three times. Foam is generated as the manufacturing process proceeds (e.g., from gas generation and / or injection). Defoaming additives are added to the liquid over a predetermined schedule over 10 days. As shown in Figure 6, the apparatus continuously measures the foam thickness in the bioreactor over extended time periods.
[0265] Example 2: Controlling the dosage of defoaming additives based on foam thickness
[0266] Figure 7 illustrates automated defoamer control using foam thickness measurements compared to a threshold thickness. Foam thickness in the container (solid line) was measured in the same manner as in Example 1 and compared to a threshold thickness. The threshold thickness (dashed line on the horizontal axis) was initially set to 10 inches and then switched to 3 inches. The dosage was set to add 20 g of defoamer additive 45 seconds after the previous defoamer additive addition if the foam thickness exceeded the threshold thickness. In the figure, no defoamer additive was added during the phase with the threshold thickness set to 10 inches because the foam thickness remained below the threshold. During the phase with the threshold thickness set to 3 inches, the first four doses were performed according to the dosage plan because the foam thickness exceeded the threshold thickness. However, in the 5th and 6th doses, the interval was adjusted so that no defoamer was added until the foam thickness reached or exceeded the threshold.
[0267] Thresholds can be set in more than one way. For example, a threshold can be set to a specific level of foam in the container relative to the current level of the liquid. In another example, a threshold can be set to the rate of change of foam thickness, adding defoamer when a rapid increase in foam thickness is detected in the container.
[0268] Figure 7 illustrates the successful automated management of foam within a container using the disclosed method. This offers significant advantages (e.g., for cell culture processes) because it ensures that the foam level is not excessively high while avoiding the addition of unnecessary defoaming additives.
[0269] Example 3: Exemplary bioreactor cell culture with automated foam control
[0270] Figure 8 depicts an exemplary automated defoaming control bioreactor cell culture system. The 2000L bioreactor contains 1200L of CHO cell culture medium, inoculated from standard cell culture seeds. The bioreactor is equipped with a load sensor that detects and reports the mass of the cell culture in the bioreactor, which is converted into liquid level based on the bioreactor's capacity and geometry. Liquid level can be measured directly by using guided wave radar instead of the load sensor. The bioreactor further includes an 80 GHz radar positioned near the top of the bioreactor. This radar is configured to transmit and receive signals to enable the determination of the level at the phase interface within the bioreactor. In this case, airborne radar is used to measure liquid or foam level, but the system may alternatively or additionally use guided wave radar.
[0271] During cell culture, which includes bubbling the cell culture medium with a gas (e.g., oxygen), foam forms and is collected on top of the cell culture medium.
[0272] The bioreactor is connected to a defoamer dosing pump, which adds a predetermined amount of liquid defoamer (e.g., Liveo™ (DuPont™), a silicone-based defoamer, including one or more of the following: simethicone; polydimethylsiloxane; and / or silica) to the bioreactor when the foam reaches a predetermined height. The amount of defoamer (dose of defoamer) is calculated for a 2000 L bioreactor; smaller or larger bioreactors require correspondingly less or more defoamer per dose.
[0273] The defoamer dosing pump's operation is controlled by a foam thickness monitoring module and a defoamer dosing control module. The foam thickness monitoring module receives liquid and foam height information from radar to calculate the foam thickness. When the foam height reaches a threshold height (i.e., when the foam layer exceeds an unacceptable height in the cell culture medium), the defoamer dosing control module instructs the defoamer dosing pump to activate, dispensing a specific dose of defoamer into the cell culture medium. The defoamer dosing control module allows users to set acceptable foam height thresholds (foam thickness thresholds), the amount of defoamer added per dose, and the delay time for adding defoamer, among other settings.
[0274] Figure 9 depicts the performance of the defoaming system during cell culture. The X-axis indicates the culture time point after initial seed culture chain cell culture. (Note that the sedimentation seen at approximately time point 326 may be due to foam sedimentation without defoamer, and the sedimentation seen at time point 456 is due to manual foam addition.) The left Y-axis indicates the number of inches of foam in the bioreactor, and the right Y-axis indicates the bioreactor weight (in kilograms). The ascending step line to the right represents the bioreactor weight after cell culture medium addition, seed culture chain cell culture, cell culture replenishment, and defoamer input. The line at the bottom of the figure indicates the number of times the defoamer pump was turned on when there was a peak (short vertical line). The step line, typically descending from left to right, represents the user-set foam thickness threshold. The sawtooth line represents the actual foam thickness measured during the cell culture process. This line indicates that foam thickness increases during cell culture and spraying, and then drops sharply after the defoamer addition pump is turned on.
[0275] As shown in Figure 9, when the defoamer addition control module is set to allow foam thickness up to 30 inches, the foam thickness is initially allowed to rise to nearly 25 inches. When the desired threshold foam thickness is reset, the foam thickness responds rapidly to the addition of defoamer. For example, when the foam thickness threshold decreases from 30 inches to 20 inches at time point 1 minute, the foam thickness decreases rapidly, and then the foam thickness follows the threshold, becoming 14 inches at time point 716, then 17 inches at time point 846, and then 15 inches at time point 920, as indicated by the sharp decrease in foam thickness due to automatic foam addition when the set foam thickness threshold is reached. Foam thickness was tracked over approximately 3600 minutes of cell culture time.
[0276] All references cited in this article are hereby incorporated in their entirety.
Claims
1. A method for monitoring and controlling foam within a container containing liquid, the method comprising: a) Measure the thickness of foam inside a container containing liquid; as well as b) Control the dosage of the defoaming additive to be added to the liquid based on the measured thickness of the foam; The thickness of the foam in step a is determined based on the difference between the level at the phase interface and the level of the liquid; and The level of the phase interface is determined by a signal emitted toward and reflected from the phase interface.
2. The method according to claim 1, wherein the phase interface is the interface between the foam in the container and the headspace gas.
3. The method of claim 1, wherein the signal comprises radio waves in the range of 26 GHz to 170 GHz.
4. The method of claim 1, wherein the signal is emitted toward and reflected from different locations of the phase interface.
5. The method of claim 1, wherein the level of the liquid is determined by volume measurement and / or size measurement associated with the liquid.
6. The method of claim 4, wherein the level of the liquid is determined by measuring the volume of the liquid.
7. The method of claim 6, wherein the volume is determined based on the mass of the liquid.
8. The method of claim 1, wherein the level at the phase interface and the level of the liquid are each measured substantially simultaneously.
9. The method of claim 1, wherein the dosage of the defoaming additive is controlled by comparing the measured thickness of the foam with a threshold thickness of the foam.
10. The method of claim 9, wherein the dosage of the defoaming additive is determined at least in part by the deviation of the measured level from the threshold level.
11. The method of claim 7, wherein the threshold level is determined at least in part based on the available headspace in the container.
12. The method of claim 1, wherein the dosage of the defoaming additive is controlled by adjusting the interval between additions of the defoaming additive and / or the amount of the defoaming additive added at one time.
13. The method of claim 1, wherein the container is a bioreactor with a volume ranging from about 1 L to about 50,000 L.
14. The method according to claim 1, wherein the liquid is a cell culture medium containing cell culture medium and cells.
15. The method of claim 14, wherein the method is performed during the duration of batch culture, fed-batch culture, or perfusion culture.
16. The method of claim 15, wherein the method is repeated multiple times during the duration of the culture.
17. The method of claim 16, wherein the repetition is induced by adding or subtracting a certain amount of liquid from the container and / or over a period of time.
18. The method of claim 12, wherein the method is repeated substantially continuously over the duration of the culture.
19. A method for producing a biological agent from cells, the method comprising: a) The cells are cultured in a cell culture medium in a bioreactor; b) Measure the thickness of the foam within the bioreactor containing the cell culture medium; c) Control the dosage of the defoaming additive to be added to the cell culture medium based on the measured thickness of the foam; as well as d) Obtain the biological agent produced by the cultured cells; The thickness of the foam in step b is determined based on the difference between the level at the phase interface and the level in the cell culture medium; and The phase interface is determined by a signal emitted toward and reflected from the phase interface.
20. The method of claim 19, wherein the phase interface is the interface between the foam in the container and the headspace gas.
21. The method of claim 19, wherein the level of the phase interface is determined based on the time elapsed between the emission of the signal and the detection of the reflected signal.
22. The method of claim 21, wherein the signal comprises any one of: electromagnetic radio waves; or radio waves.
23. The method of claim 21, wherein the signal comprises radio waves in the range of 26 GHz to 170 GHz.
24. The method of claim 19, wherein the signal is emitted toward and reflected from different locations of the phase interface.
25. The method of claim 19, wherein the level of the cell culture medium is determined by volume measurement and / or size measurement associated with the cell culture medium.
26. The method of claim 25, wherein the level of the cell culture medium is determined by a volume measurement associated with the cell culture medium, and wherein the volume measurement is based on the mass of the cell culture medium.
27. The method of claim 19, wherein the level at the phase interface and the level in the cell culture medium are each measured substantially simultaneously.
28. The method of claim 19, wherein the dosage of the defoaming additive is controlled by comparing the measured thickness of the foam with a threshold thickness of the foam.
29. The method of claim 28, wherein the dosage of the defoaming additive is determined at least in part by the deviation of the measured level from the threshold level.
30. The method of claim 28, wherein the threshold level is determined at least in part based on the available headspace in the container.
31. The method of claim 19, wherein the dosage of the defoaming additive is controlled by adjusting the interval between additions of the defoaming additive and / or the amount of the defoaming additive added at one time.
32. The method of claim 19, wherein the bioreactor has a volume in the range of about 1 L to about 50,000 L.
33. The method of claim 19, wherein the cell culture medium comprises cell culture medium and cells.
34. The method of claim 19, wherein steps b) and c) are performed during the duration of batch culture, fed-batch culture, or perfusion culture.
35. The method of claim 31, wherein steps b) and c) are repeated multiple times during the duration of the culture.
36. The method of claim 35, wherein the repetition of steps b) and c) is induced by adding or subtracting a certain amount of cell culture medium from the container and / or over a period of time.
37. The method of claim 34, wherein steps b) and c) are repeated substantially continuously over the duration of the culture.
38. The method of claim 34, wherein step d) is performed only at approximately the end of the culture duration.
39. The method of claim 19, wherein step d) comprises isolating the biological agent from the cell culture medium.
40. The method of claim 39, wherein the biological agent is at least one recombinant polypeptide and the cell is a eukaryotic cell containing a polynucleotide encoding the recombinant polypeptide.
41. The method of claim 40, wherein the at least one recombinant polypeptide is selected from fusion proteins, antibodies, antigens, enzymes, or vaccines.
42. An apparatus for controlling the thickness of foam within a container containing liquid, the apparatus comprising: A container configured to contain a liquid; A phase interface level measuring device configured to measure the level at a phase interface, the phase interface level measuring device comprising: A transmitter configured to transmit signals toward the phase interface; A receiver configured to detect the reflected signal from the phase interface; A liquid level measuring device configured to measure the level of the liquid in the container; as well as The processor is configured to; The thickness of the foam is determined based on the difference between the level at the phase interface and the level of the liquid. as well as The measured thickness of the foam indicates the dosage of defoaming additive to be added to the liquid.
43. The apparatus of claim 42, wherein the interface level measuring device measures the level of the interface based on the time elapsed between emitting the signal toward the interface and detecting the reflected signal.
44. The apparatus of claim 42, wherein the transmitter and / or receiver are arranged substantially perpendicular to the phase interface of the liquid in the container.
45. The apparatus of claim 42, wherein the transmitter and / or receiver is arranged above the top of the container.
46. The apparatus of claim 42, wherein the transmitter and / or receiver are arranged outside the container to transmit signals or detection signals into the interior of the container, respectively.
47. The apparatus of claim 42, wherein the transmitter and / or receiver are arranged inside the container to transmit a signal or detect a signal, respectively, within the container.
48. The apparatus of claim 42, wherein the transmitter is configured to transmit any of the following: electromagnetic radio waves; or radio waves.
49. The apparatus of claim 48, wherein the transmitter is configured to transmit radio waves in the range of 26 GHz to 170 GHz.
50. The apparatus of claim 49, wherein the liquid level measuring device is selected from a load sensor, a scale, a ranging device, and a guided wave radar.
51. The apparatus of claim 42, wherein the container is a bioreactor with a volume ranging from about 1 L to about 50,000 L.
52. The apparatus of claim 42, wherein the container is at least partially formed of a signal-permeable material, and wherein the transmitter and / or receiver are arranged to transmit or detect signals through the signal-permeable material, respectively.
53. The device of claim 52, wherein the top of the container is formed of a signal-permeable material.
54. The apparatus of claim 52, wherein the container is at least partially formed of a radio-impermeable material.
55. The apparatus of claim 42, wherein the container is at least partially formed of: stainless steel; glass; ceramic; and / or plastic film.
56. The apparatus of claim 42, wherein the container comprises at least: Partially stainless steel casing; And a plastic film liner.
57. The apparatus of claim 42, wherein the processor controls the dosage of the defoaming additive by comparing a measured thickness of the foam with a threshold thickness of the foam.
58. The apparatus of claim 57, wherein the processor controls the dosage of the defoaming additive by measuring the deviation between the measured level and the threshold level.
59. The apparatus of claim 42, wherein the processor is configured to repeatedly and / or continuously measure the thickness of the foam and indicate the dosage of the defoaming additive during the cell culture duration.
60. The apparatus of claim 42, wherein the apparatus further comprises an antifoaming additive injector configured to automatically inject the antifoaming additive into the container when the processor instructs the addition of the antifoaming additive.
61. The method according to any one of claims 1 to 41 or the apparatus according to any one of claims 42 to 60, wherein the defoaming additive is a silicone-based defoamer.
62. The method according to any one of claims 1 to 41 or the apparatus according to any one of claims 42 to 60, wherein the defoaming additive comprises one or more of the following: simethicone; polydimethylsiloxane; and / or silica.
Citation Information
Patent Citations
Use of vision systems in biomanufacturing processes
US20210355427A1
